For the sake of accuracy, the blurb at TRI appears a bit inaccurate.
It says that :
The vaccine relies on Professor Frazer's immunotherapy technology, which he successfully used to develop a vaccine for the Human Papillomavirus, distributed as Gardasil and Cervarix.
However, I thought the HSV2 vaccine uses a DNA vaccination approach, whereas Gardasil is a subunit (protein) vaccine :
The ingredients are proteins of HPV Types 6, 11, 16, and 18, amorphous aluminum hydroxyphosphate sulfate, yeast protein, sodium chloride, L-histidine, polysorbate 80, sodium borate, and water for injection. http://www.gardasil.com/about-gardasil/faqs-about-gardasil/
It also talks about clearing HSV2 from the blood, but HSV-2 reactivates in nerve ganglia and passes directly down neurons to cause skin lesions of genital herpes - it does not require blood transmission for this.
TGA, page-16
-
- There are more pages in this discussion • 7 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add AVR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$18.00 |
Change
0.000(0.00%) |
Mkt cap ! $346.0M | |||
| Open | High | Low | Value | Volume |
| $18.00 | $18.10 | $17.70 | $58.64K | 3.27K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 109 | $18.00 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $18.10 | 700 | 1 |
View Market Depth
| Last trade - 16.10pm 12/07/2024 (20 minute delay) ? |
| AVR (ASX) Chart |